Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolkowicz, J
Right arrow Articles by Chan, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wolkowicz, J
Right arrow Articles by Chan, C.

Chest, Vol 101, 97-101, Copyright © 1992 by American College of Chest Physicians

ARTICLES

Bleomycin-induced pulmonary function abnormalities

J Wolkowicz, J Sturgeon, M Rawji and CK Chan
Department of Medicine, Wellesley Hospital, University of Toronto, Ontario, Canada.

The usefulness of serial PFTs in identifying patients who are developing BIP was assessed in 59 men with non-seminomatous testicular carcinoma. The mean age was 27.7 years and all the patients received a standard three-course chemotherapy regimen consisting of vinblastine, bleomycin, and cis-diamminedichloroplatinum. The average dose of bleomycin was 555.5 units. Serial PFTs, chest roentgenograms, and medical assessments were done prior to each course of bleomycin. Nine (15.3 percent) patients developed pulmonary symptoms due to bleomycin and 23 (39 percent) had significant changes on chest x-ray films. The Dsb dropped significantly with bleomycin treatment; therefore, it is the most sensitive indicator of pulmonary response to bleomycin. However, the Dsb failed to differentiate patients with BIP from those without. The TLC was found to be a much more specific indicator of BIP because reduction in TLC correlated with the development of pulmonary symptoms and roentgenologic changes.


This article has been cited by other articles:


Home page
 ChestHome page
E. Azoulay, H. Attalah, A. Harf, B. Schlemmer, and C. Delclaux
Granulocyte Colony-Stimulating Factor or Neutrophil-Induced Pulmonary Toxicity: Myth or Reality? : Systematic Review of Clinical Case Reports and Experimental Data
Chest, November 1, 2001; 120(5): 1695 - 1701.
[Full Text] [PDF]

Home page
 ChestHome page
S. Sleijfer
Bleomycin-Induced Pneumonitis
Chest, August 1, 2001; 120(2): 617 - 624.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Chest Physicians.